{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T04:36:46Z","timestamp":1784349406063,"version":"3.55.0"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1097\/qco.0b013e328358b000","type":"journal-article","created":{"date-parts":[[2012,9,8]],"date-time":"2012-09-08T08:28:21Z","timestamp":1347092901000},"page":"612-618","source":"Crossref","is-referenced-by-count":23,"title":["Risks for infection in patients with myelodysplasia and acute leukemia"],"prefix":"10.1097","volume":"25","author":[{"given":"Livio","family":"Pagano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morena","family":"Caira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210205","first-page":"1068","article-title":"The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study.","volume":"91","author":"Pagano","year":"2006","journal-title":"Haematologica"},{"key":"R2-3-20210205","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/595846","article-title":"Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.","volume":"48","author":"Neofytos","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R3-3-20210205","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/MPH.0b013e3181b1edc6","article-title":"Etiology and clinical course of febrile neutropenia in children with cancer.","volume":"31","author":"Hakim","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"key":"R4-3-20210205","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s12032-009-9330-9","article-title":"Infections in acute myeloid leukemia: an analysis of 382 febrile episodes.","volume":"27","author":"Gupta","year":"2010","journal-title":"Med Oncol"},{"key":"R5-3-20210205","first-page":"569","article-title":"EORTC International Antimicrobial Therapy Cooperative Group.","volume":"26","year":"1990","journal-title":"Eur J Cancer"},{"key":"R6-3-20210205","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1086\/522533","article-title":"A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation.","volume":"45","author":"Castagnola","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R7-3-20210205","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1469-0691.2005.01298.x","article-title":"Risk of bacteraemia and mortality in patients with haematological malignancies.","volume":"12","author":"Norgaard","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"R8-3-20210205","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00277-011-1373-2","article-title":"A prospective survey of febrile events in hematological malignancies.","volume":"91","author":"Pagano","year":"2012","journal-title":"Ann Hematol"},{"key":"R9-3-20210205","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1001\/archinternmed.2011.374","article-title":"Etiology of febrile episodes in patients with acute myeloid leukemia: results from the Hema e-Chart Registry.","volume":"171","author":"Pagano","year":"2011","journal-title":"Arch Intern Med"},{"key":"R10-3-20210205","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/j.semdp.2011.08.005","article-title":"Myelodysplastic syndromes.","volume":"28","author":"Zhou","year":"2011","journal-title":"Semin Diagn Pathol"},{"key":"R11-3-20210205","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1002\/cncr.24984","article-title":"Cause of death in patients with lower-risk myelodysplastic syndrome.","volume":"116","author":"Dayyani","year":"2010","journal-title":"Cancer"},{"key":"R12-3-20210205","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/cncr.24894","article-title":"Azacitidine for the treatment of lower risk myelodysplastic syndromes.","volume":"116","author":"Musto","year":"2010","journal-title":"Cancer"},{"key":"R13-3-20210205","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(09)70003-8","article-title":"Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.","volume":"10","author":"Fenaux","year":"2009","journal-title":"Lancet Oncol"},{"key":"R14-3-20210205","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1600-0609.2010.01443.x","article-title":"Sepsis in acute myeloid leukaemia patients receiving high-dose chemotherapy: no impact of chitotriosidase and mannose-binding lectin polymorphisms.","volume":"85","author":"Klostergaard","year":"2010","journal-title":"Eur J Haematol"},{"key":"R15-3-20210205","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.3109\/10428194.2012.661858","article-title":"Variation in Toll-like receptor 9 gene modifies the risk of infection in children treated for acute lymphoblastic leukemia.","volume":"53","author":"Bhadri","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"R16-3-20210205","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3109\/10408410903530619","article-title":"Genetic susceptibility to infections with Aspergillus fumigatus.","volume":"36","author":"Mezger","year":"2010","journal-title":"Crit Rev Microbiol"},{"key":"R17-3-20210205","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1086\/526500","article-title":"Polymorphisms in Toll-like receptor genes and susceptibility to pulmonary aspergillosis.","volume":"197","author":"Carvalho","year":"2008","journal-title":"J Infect Dis"},{"key":"R18-3-20210205","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.exphem.2009.06.004","article-title":"Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation.","volume":"37","author":"Carvalho","year":"2009","journal-title":"Exp Hematol"},{"key":"R20-3-20210205","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jinf.2009.02.002","article-title":"Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies.","volume":"58","author":"Trecarichi","year":"2009","journal-title":"J Infect"},{"key":"R21-3-20210205","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/jac\/dkm514","article-title":"Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution.","volume":"61","author":"Cattaneo","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"R22-3-20210205","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1128\/AAC.00234-12","article-title":"In vivo emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli.","volume":"56","author":"Spanu","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"R23-3-20210205","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/00001432-200012000-00006","article-title":"The changing spectrum of candidemia in oncology patients: therapeutic implications.","volume":"13","author":"Marr","year":"2000","journal-title":"Curr Opin Infect Dis"},{"key":"R24-3-20210205","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jcrc.2011.04.007","article-title":"Acinetobacter baumannii infection in patients with hematologic malignancies in intensive care unit: risk factors and impact on mortality.","volume":"26","author":"Turkoglu","year":"2011","journal-title":"J Crit Care"},{"key":"R25-3-20210205","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jcrc.2011.08.020","article-title":"Multidrug-resistant Acinetobacter baumannii infection is not an independent risk factor for mortality in critically ill patients with hematologic malignancy.","volume":"26","author":"Turkoglu","year":"2011","journal-title":"J Crit Care"},{"key":"R27-3-20210205","first-page":"1076","article-title":"Infectious complications of acute leukemia.","volume":"94","author":"Bodey","year":"1966","journal-title":"Med Times"},{"key":"R28-3-20210205","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1182\/blood.V101.3.1172","article-title":"Decreased phosphorylation of protein kinase B (PKBAkt) and extracellular signal-regulated kinase (ERK) in neutrophils from patients with myelodysplasia.","volume":"101","author":"Fuhler","year":"2003","journal-title":"Blood"},{"key":"R29-3-20210205","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1189\/jlb.0504306","article-title":"Impaired interleukin-8- and GRO-induced phosphorylation of extracellular signal-regulated kinase result in decreased migration of neutrophils from patients with myelodysplasia.","volume":"77","author":"Fuhler","year":"2005","journal-title":"J Leuk Biol"},{"key":"R30-3-20210205","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1189\/jlb.0506311","article-title":"The reduced n priming of ROS production in granulocytes from patients with myelodysplasia is associated with an impaired lipid raft formation.","volume":"81","author":"Fuhler","year":"2007","journal-title":"J Leukoc Biol"},{"key":"R31-3-20210205","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.leukres.2011.11.012","article-title":"Impaired bactericidal and fungicidal activities of neutrophils in patients with myelodysplastic syndrome.","volume":"36","author":"Fianchi","year":"2012","journal-title":"Leuk Res"},{"key":"R32-3-20210205","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12185-009-0412-4","article-title":"Suppressed neutrophil function in children with acute lymphoblastic leukemia.","volume":"90","author":"Tanaka","year":"2009","journal-title":"Int J Hematol"},{"key":"R33-3-20210205","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1182\/blood-2008-07-172007","article-title":"Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry.","volume":"113","author":"Juliusson","year":"2009","journal-title":"Blood"},{"key":"R34-3-20210205","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1080\/10428190410001683660","article-title":"Infectious complications in adult acute lymphoblastic leukemia (ALL): experience at one single center.","volume":"45","author":"Offidani","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"R35-3-20210205","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/cncr.20071","article-title":"Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasonemethotrexate-cytarabine regimen.","volume":"100","author":"Weiser","year":"2004","journal-title":"Cancer"},{"key":"R37-3-20210205","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1086\/502598","article-title":"Catheter-related vancomycin-resistant Enterococcus faecium bacteremia: clinical and molecular epidemiology.","volume":"26","author":"Raad","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R38-3-20210205","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1086\/653935","article-title":"Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials.","volume":"51","author":"Nucci","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R39-3-20210205","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nrmicro1046","article-title":"Iron and microbial infection.","volume":"2","author":"Schaible","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"R40-3-20210205","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1023\/A:1009293500209","article-title":"Microbial pathogens with impaired ability to acquire host iron.","volume":"13","author":"Weinberg","year":"2000","journal-title":"Biometals"},{"key":"R41-3-20210205","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1099\/jmm.0.46386-0","article-title":"Natural resistance, iron and infection: a challenge for clinical medicine.","volume":"55","author":"Bullen","year":"2006","journal-title":"J Med Microbiol"},{"key":"R42-3-20210205","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1086\/518040","article-title":"The effect of the hosts iron status on tuberculosis.","volume":"195","author":"Boelaert","year":"2007","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"R43-3-20210205","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1089\/sur.2005.6.s1-41","article-title":"Iron and the risk of infection.","volume":"6","author":"Pieracci","year":"2005","journal-title":"Surg Infect"},{"key":"R44-3-20210205","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/cncr.22909","article-title":"Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation.","volume":"110","author":"Kontoyiannis","year":"2007","journal-title":"Cancer"},{"key":"R45-3-20210205","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1182\/blood-2007-07-100669","article-title":"Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin.","volume":"111","author":"de la Serna","year":"2008","journal-title":"Blood"},{"key":"R46-3-20210205","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s005200100248","article-title":"Infectious complications in children with acute lymphoblastic leukemia and T-cell lymphoma- a rationale for tailored supportive care.","volume":"9","author":"Lex","year":"2001","journal-title":"Support Care Cancer"},{"key":"R47-3-20210205","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1016\/j.leukres.2011.05.028","article-title":"Infections in relapsed or refractory acute myeloid leukemia patients given clofarabine cytarabine.","volume":"35","author":"Knoebel","year":"2011","journal-title":"Leuk Res"},{"key":"R48-3-20210205","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1097\/MPH.0b013e31822817a6","article-title":"Life-threatening and fatal infections in children with acute myeloid leukemia: a report from the Childrens Oncology Group.","volume":"34","author":"Sung","year":"2012","journal-title":"J Pediatr Hematol Oncol"},{"key":"R49-3-20210205","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3109\/10428194.2011.636812","article-title":"Infectious complications in adult acute myeloid leukemia: analysis of the Acute Leukemia French Association-9802 prospective multicenter clinical trial.","volume":"53","author":"Cannas","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"R50-3-20210205","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMoa1010222","article-title":"Cytarabine dose for acute myeloid leukemia.","volume":"364","author":"Lowenberg","year":"2011","journal-title":"N Engl J Med"},{"key":"R51-3-20210205","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1056\/NEJMoa0901409","article-title":"High-dose daunorubicin in older patients with acute myeloid leukemia.","volume":"361","author":"Lowenberg","year":"2009","journal-title":"N Engl J Med"},{"key":"R52-3-20210205","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJMoa0904544","article-title":"Anthracycline dose intensification in acute myeloid leukemia.","volume":"361","author":"Fernandez","year":"2009","journal-title":"N Engl J Med"},{"key":"R53-3-20210205","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.beha.2009.12.004","article-title":"Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches.","volume":"23","author":"Morrison","year":"2010","journal-title":"Best Pract Res Clin Haematol"},{"key":"R54-3-20210205","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/sj.bmt.1704543","article-title":"Risk factors for postengraftment invasive aspergillosis in allogeneic stem cell transplantation.","volume":"34","author":"Thursky","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"R55-3-20210205","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S1470-2045(10)70114-5","article-title":"Glucocorticoid use in acute lymphoblastic leukaemia.","volume":"11","author":"Inaba","year":"2010","journal-title":"Lancet Oncol"},{"key":"R57-3-20210205","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2217\/fon.09.20","article-title":"Treatment of acute myeloid leukemia with hematopoietic stem cell transplantation.","volume":"5","author":"Jones","year":"2009","journal-title":"Future Oncol"},{"key":"R58-3-20210205","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/CCO.0b013e32834f5c41","article-title":"Allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia in adults.","volume":"24","author":"Khaled","year":"2012","journal-title":"Opin Oncol"},{"key":"R59-3-20210205","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.hoc.2010.02.003","article-title":"Hematopoietic stem cell transplantation for MDS.","volume":"24","author":"Bartenstein","year":"2010","journal-title":"Hematol Oncol Clin North Am"},{"key":"R60-3-20210205","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00277-011-1351-8","article-title":"Cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation: experience in a center with a high seroprevalence of both CMV and hepatitis B virus.","volume":"91","author":"Liu","year":"2012","journal-title":"Ann Hematol"},{"key":"R62-3-20210205","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R63-3-20210205","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3349\/ymj.2012.53.2.393","article-title":"Cytomegalovirus infection according to cell source after hematopoietic cell transplantation in pediatric patients.","volume":"53","author":"Yi","year":"2012","journal-title":"Yonsei Med J"},{"key":"R64-3-20210205","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/sj.bmt.1705561","article-title":"Risk factor analysis of blood stream infection and pneumonia in neutropenic patients after peripheral blood stem-cell transplantation.","volume":"39","author":"Meyer","year":"2007","journal-title":"Bone Marrow Transplant"}],"container-title":["Current Opinion in Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QCO.0b013e328358b000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T01:23:56Z","timestamp":1714353836000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001432-201212000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/qco.0b013e328358b000","relation":{},"ISSN":["0951-7375"],"issn-type":[{"value":"0951-7375","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}